Sphera Funds Management’s Molecular Partners MOLN Stock Holding History

Sphera Funds Management’s Portfolio MOLN Stock Details MOLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-80,555	Closed	-$1.58M	–	114
2021 Q3	$1.58M	Buy	+80,555	New	+$1.58M	0.13%	99

Other funds holding MOLN

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Sphera Funds Management's MOLN Position: Q4 2021 in Review

Sphera Funds Management sold out of Molecular Partners (MOLN) in Q4 2021, closing a stake of 80,555 shares — an estimated $1.58M sold.

Sphera Funds Management first reported a position in MOLN in Q3 2021 and held it in 1 quarter. The position peaked at $1.58M in Q3 2021. 9 funds tracked by Wall St. Rank hold MOLN as of Q4 2021.

Sphera Funds Management reported no remaining Molecular Partners position as of Q4 2021 after selling out during the quarter.
Sphera Funds Management sold 80,555 Molecular Partners shares in Q4 2021, an estimated $1.58M.
Sphera Funds Management first reported a position in Molecular Partners in Q3 2021 and held it in 1 quarter.
Sphera Funds Management's Molecular Partners position peaked at $1.58M in Q3 2021.
9 funds tracked by Wall St. Rank held Molecular Partners as of Q4 2021.

Based on Sphera Funds Management's 13F filing for Q4 2021, filed 14 Feb 2022.